Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.02 SEK | -0.49% |
|
-2.98% | +4.11% |
Strengths
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.11% | 105.41Cr | B | ||
-5.60% | 18TCr | C+ | ||
-4.45% | 10TCr | C | ||
-4.15% | 6.75TCr | A | ||
-8.63% | 4.51TCr | B- | ||
+9.70% | 4.44TCr | B- | ||
+6.13% | 4.07TCr | B+ | ||
+15.22% | 2.98TCr | B | ||
+14.80% | 2.45TCr | A- | ||
-6.46% | 2.4TCr | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ARJO B Stock
- Ratings Arjo AB